UPDATE : Friday, July 10, 2020
상단여백
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab by Jeong Sae-im 2019-11-19 17:18
‘New law needed to curb rising chronic kidney disease’ by Jeong Sae-im 2019-11-19 11:45
‘Udenafil improved exercise in single ventricle heart disease’ by Jeong Sae-im 2019-11-18 14:48
Prosecutors raid drugmakers, distributors for suspected bid-rigging by Jeong Sae-im 2019-11-14 15:27
How can Korean drugmakers enter Europe successfully? by Jeong Sae-im 2019-11-13 15:22
라인
Samsung Bioepis expects ₩1 trillion biosimilar sales this year by Jeong Sae-im 2019-11-13 15:21
[News Focus] ‘FDA could allow resumption of Invossa trial’ by Jeong Sae-im 2019-11-12 15:48
Eunpyeong St. Mary’s Hospital adopts AI nursing documentation by Jeong Sae-im 2019-11-12 15:47
Genexine’s new immunotherapy shows stability even in high dose by Jeong Sae-im 2019-11-11 13:36
‘Cancer patients suffered side effects after taking anthelmintic drug’ by Jeong Sae-im 2019-11-08 13:30
라인
‘Lung cancer screening was effective in numerous studies’ by Jeong Sae-im 2019-11-07 14:06
Court rejects arrest warrant for 2 Kolon execs by Jeong Sae-im 2019-11-05 13:54
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals by Jeong Sae-im 2019-11-04 15:52
Kolon allegedly knew Inovossa mislabeling before applying for approval by Jeong Sae-im 2019-11-01 15:07
Prosecutors seek to arrest 2 Kolon execs for false Invossa data by Jeong Sae-im 2019-10-31 15:34
라인
Regulator to do quality test on botulinum toxin products by Jeong Sae-im 2019-10-31 14:24
Syntekabio passes prior review for Kosdaq listing by Jeong Sae-im 2019-10-31 13:27
71 pharmaceutical CEOs gather to boost new drug development by Jeong Sae-im 2019-10-30 12:40
Prosecution seeks jail term for Samsung execs for destroying evidence by Jeong Sae-im 2019-10-29 13:10
KangStem Biotech changes strategy for atopic dermatitis drug by Jeong Sae-im 2019-10-28 15:34
여백
여백
여백
Back to Top